Riskpilot← Back to searchSign inGet full accessAbcur AB
ABActiveOrg 5567013957Bergaliden 11 2trWholesale of pharmaceutical and medical goods · NACE 4646Est. 200611 employees
Revenue 2024
SEK 177,4M
+41% vs 2023
EBITDA margin
15.9%
-16% vs 2023
Equity ratio
37.3%
Financial strength
Net profit 2024
SEK 22,9M
-15% vs 2023
| Revenue | SEK 177,4M | +41% |
| EBITDA | SEK 28,2M | -16% |
| Net profit | SEK 22,9M | -15% |
| Total assets | SEK 95,2M | -15% |
| Equity | SEK 35,5M | -58% |
| Employees | 11 | — |
Legal name
Abcur AB
Org number
5567013957
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4 april 2006
Share capital
SEK 100 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva försäljning av läkemedel, läkemedelsnära produkter och annan därmed förenlig verksamhet. Konsultverksamhet inom ovan nämnda områden. Bolaget skall även bedriva handel med värdepapper samt därmed förenlig verksamhet. Bolaget skall dessutom förvalta fast egendom samt därmed förenlig verksamhet.
Address
Bergaliden 11 2tr
Phone
+4642135770
Email
info@abcur.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 128 445 | 107 894 | 103 926 | 125 368 | 177 386 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 33 739 | 19 612 | 20 324 | 33 513 | 28 153 |
| Depreciation & amort. | −1 203 | −713 | −1 148 | −200 | −407 |
| EBIT | 32 536 | 18 899 | 19 176 | 33 313 | 27 746 |
| Net financials | −1 434 | −2 097 | −498 | 996 | 969 |
| Profit before tax | 33 687 | 16 841 | 18 869 | 34 309 | 28 881 |
| Tax | −7 383 | −3 378 | −4 085 | −7 309 | −5 990 |
| Net profit | 26 304 | 13 463 | 14 784 | 27 000 | 22 891 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 93 467 | 84 755 | 90 721 | 111 664 | 95 249 |
| Equity | 27 715 | 41 178 | 56 628 | 83 628 | 35 519 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 63 083 | 43 577 | 34 093 | 28 036 | 57 101 |
| Total debt | 63 083 | 43 577 | 34 093 | 28 036 | 57 101 |
EBITDA margin
15.9%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
37.3%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
64.4%
This company
18.4%
Market median
+250% vs market
20202024
Net profit margin
12.9%
This company
8.1%
Market median
+59% vs market
20202024
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
20202024
Debt / equity
1.68×
This company
0.62×
Market median
-171% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PR Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
PI Chief Auditor | Chief Auditor | 2022 – 2025 |
CJ Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MERCURY PHARMA GROUP LIMITED
Abcur AB (this company)Board members of Abcur AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Richard Kjellander | Chief Auditor | 0 companies |
| Patricia Isabella Pålsson | Chief Auditor | 0 companies |
| Christer Jan-Erik Kilefors | Chief Auditor | 0 companies |
| Karl Nicke Flink | Chairman | 0 companies |
| Simon Tucker | Board of Directors | 0 companies |
| Andreas Stickler | Board of Directors | 0 companies |
| Michael Cullen | Board of Directors | 0 companies |
| Adeel Ahmad | Board of Directors | 0 companies |
| David Alexander McNamara | Board of Directors | 0 companies |